Carnosinemia

From WikiMD's Wellness Encyclopedia

Carnosinemia
Synonyms Carnosinase deficiency[1] or Aminoacyl-histidine dipeptidase deficiency,[2]
Pronounce
Field
Symptoms
Complications
Onset
Duration
Types
Causes
Risks
Diagnosis
Differential diagnosis
Prevention
Treatment
Medication
Prognosis
Frequency
Deaths


Carnosinemia, is a rare autosomal recessive[3] metabolic disorder[4] caused by a deficiency of carnosinase', a dipeptidase (a type of enzyme that splits dipeptides into their two amino acid constituents).[5]

Carnosine is a dipeptide composed of beta-alanine and histidine, and is found in skeletal muscle and cells of the nervous system.[6] This disorder results in an excess of carnosine in the urine, cerebrospinal fluid, blood, and nervous tissue.[7] Neurological disorders associated with a deficiency of carnosinase, and the resulting carnosinemia ("carnosine in the blood") are common.[3][8][9]

Symptoms[edit | edit source]

A variety of neurological symptoms have been associated with carnosinemia. They include: hypotonia, developmental delay, mental retardation, degeneration of axons, sensory neuropathy, tremors, demyelinization, gray matter anomalies, myoclonic seizures, and loss of purkinje fibers.[3][4][8][9]

Genetics[edit | edit source]

Carnosinemia has an autosomal recessive pattern of inheritance.

The gene for carnosinase is located on chromosome 18,[3] an autosome. The carnosine dipeptidase-1 gene (CNDP1) controls tissue and serum carnosinase.[10] Mutations in CNDP1 are responsible for carnosinase deficiency, resulting in carnosinemia.[3]

Carnosinemia is an autosomal recessive disorder,[3] which means the defective gene is located on an autosome, and two copies of the defective gene - one from each parent - are required to inherit the disorder. The parents of an individual with an autosomal recessive disorder both carry one copy of the defective gene, but usually do not experience any signs or symptoms of the disorder.

Diagnosis[edit | edit source]

Types[edit | edit source]

Carnosinase in humans has two forms:[11][12][13][14]

1. Cellular, or tissue carnosinase:[12] This form of the enzyme is found in every bodily tissue. It is a dimer, and hydrolyzes both carnosine and anserine, preferring dipeptides that have a histidine monomer in the C-terminus position.[11][12] Tissue carnosinase is often considered a "nonspecific dipeptidase",[13][15] based in part on its ability to hydrolyze a range of dipeptide substrates, including those belonging to prolinase.[16]

2. Serum carnosinase:[14] This is the carnosinase found in the blood plasma. Deficiency of this form of carnosinase, along with carnosinuria ("carnosine in the urine"), is the usual metabolic indicator of systemic carnosinase deficiency.[3][8][17] Serum carnosinase is a glycoprotein, and splits free carnosine and anserine in the blood.[11] This form of the dipeptidase is not found in human blood until late infancy, slowly rising to adult levels by age 15.[14] Unlike tissue carnosinase, serum carnosinase also hydrolyzes the GABA metabolite homocarnosine.[11] Homocarnosinosis, a neurological disorder resulting in an excess of homocarnosine in the brain, though unaffected by tissue carnosinase, is caused by a deficiency of serum carnosinase in its ability to hydrolyze homocarnosine.[18]

A deficiency of tissue and serum carnosinase, with serum being an indicator, is the underlying metabolic cause of carnosinemia.[7][9]


See also[edit | edit source]

References[edit | edit source]

  1. ↑ Online Mendelian Inheritance in Man (OMIM) 212200
  2. ↑ DDB 29672
  3. ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 , A deletion in the long arm of chromosome 18 in a child with serum carnosinase deficiency, Pediatr. Res., 1997, Vol. 41(Issue: 2), pp. 210–213, DOI: 10.1203/00006450-199702000-00009, PMID: 9029640,
  4. ↑ 4.0 4.1 , Carnosinemia. A new metabolic disorder associated with neurological disease and mental defect, N. Engl. J. Med., 1967, Vol. 277(Issue: 23), pp. 1219–1227, DOI: 10.1056/NEJM196712072772302, PMID: 6058610,
  5. ↑ , L-carnosine, a substrate of carnosinase-1, influences glucose metabolism, Diabetes, 2007, Vol. 56(Issue: 10), pp. 2425–2432, DOI: 10.2337/db07-0177, PMID: 17601992,
  6. ↑ , Carnosine and its constituents inhibit glycation of low-density lipoproteins that promotes foam cell formation in vitro, FEBS Lett., 2007, Vol. 581(Issue: 5), pp. 1067–1070, DOI: 10.1016/j.febslet.2007.01.082, PMID: 17316626,
  7. ↑ 7.0 7.1 , Inborn errors of carnosine and homocarnosine metabolism, J Neural Transm Suppl, 1990, Vol. 29 pp. 91–106, DOI: 10.1007/978-3-7091-9050-0_10, PMID: 2358806,
  8. ↑ 8.0 8.1 8.2 , Histopathology of the nervous system in carnosinase enzyme deficiency with mental retardation, Neurology, 1972, Vol. 22(Issue: 6), pp. 644–655, DOI: 10.1212/wnl.22.6.644, PMID: 4673339,
  9. ↑ 9.0 9.1 9.2 , Neurological diseases in a child with carnosinase deficiency, Neuropediatrics, 1981, Vol. 12(Issue: 2), pp. 143–151, DOI: 10.1055/s-2008-1059647, PMID: 7266778,
  10. ↑ , Allelic variation in the CNDP1 gene and its lack of association with longevity and coronary heart disease, Mech Ageing Dev., 2006, Vol. 127(Issue: 11), pp. 817–820, DOI: 10.1016/j.mad.2006.08.002, PMID: 16965804,
  11. ↑ 11.0 11.1 11.2 11.3 , Purification and properties of human serum carnosinase, Clin Chim Acta, 1991, Vol. 196(Issue: 2–3), pp. 193–205, DOI: 10.1016/0009-8981(91)90073-L, PMID: 1903095,
  12. ↑ 12.0 12.1 12.2 , Characterization of human tissue carnosinase, Biochem. J., 1985, Vol. 228(Issue: 3), pp. 653–660, DOI: 10.1042/bj2280653, PMID: 4026801, PMC: 1145034,
  13. ↑ 13.0 13.1 Lenney JF, Separation and characterization of two carnosine-splitting cytosolic dipeptides from hog kidney (carnosinase and non-specific dipeptidase), Biol Chem Hoppe-Seyler, 1990, Vol. 371(Issue: 5), pp. 433–440, DOI: 10.1515/bchm3.1990.371.1.433, PMID: 2378680,
  14. ↑ 14.0 14.1 14.2 , Human serum carnosinase: characterization, distinction from cellular carnosinase and activation by cadmium, Clin Chim Acta, 1982, Vol. 123(Issue: 3), pp. 221–231, DOI: 10.1016/0009-8981(82)90166-8, PMID: 7116644,
  15. ↑ , Bestatin inhibition of human tissue carnosinase, a non-specific cytosolic dipeptidase, Biol Chem Hoppe-Seyler, 1988, Vol. 369(Issue: 12), pp. 1281–1286, DOI: 10.1515/bchm3.1988.369.2.1281, PMID: 3242551,
  16. ↑ Lenney JF, Human cytosolic carnosinase: evidence of identity with prolinase, a non-specific dipeptidase, Biol Chem Hoppe-Seyler, 1990, Vol. 371(Issue: 2), pp. 167–171, DOI: 10.1515/bchm3.1990.371.1.167, PMID: 2334521,
  17. ↑ , A patient with a deficiency of serum-carnosinase activity, Acta Paediatr. Scand., 1969, Vol. 58(Issue: 6), pp. 584–592, DOI: 10.1111/j.1651-2227.1969.tb04766.x, PMID: 5378348,
  18. ↑ , Homocarnosinosis: lack of serum carnosinase is the deficiency probably responsible for elevated brain and CSF homocarnosine, Clin Chim Acta, 1983, Vol. 132(Issue: 2), pp. 157–165, DOI: 10.1016/0009-8981(83)90243-7, PMID: 6616870,


External links[edit | edit source]

Classification
External resources


Medicine-stub.png
This article is a stub related to medicine. You can help WikiMD by expanding it!
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.com/w/index.php?title=Carnosinemia&oldid=5192581"

Contributors: Prab R. Tumpati, MD